Table 1. Correlation of PSCA-expression with clinico-pathological parameter.
| PSCA negative | PSCA low | PSCA high | p-value | |
|---|---|---|---|---|
| Her-2/neu status | ||||
| HER2-positive | 77 (25.1) | 28 (44.4) | 16 (59.3) | < 0.001 |
| HER2-negative | 230 (74.9) | 35 (55.6) | 11 (40.7) | |
| histopathological grade | ||||
| G1 | 41 (13.2) | 5 (7.6) | 0.011 | |
| G2 | 124 (39.9) | 25 (37.9) | 10 (35.7) | |
| G3 | 146 (46.9) | 36 (54.5) | 18 (64.3) | |
| Ki67 proliferation index | ||||
| 0-9% | 126 (41.3) | 21 (31.8) | 4 (14.3) | 0.006 |
| 10-20% | 81 (26.6) | 18 (27.3) | 11 (39.3) | |
| >20% | 98 (32.1) | 27 (40.9) | 13 (46.4) | |
| Age, n (%) | ||||
| ≤ 50 years | 89 (28.6) | 11 (16.7) | 6 (21.4) | 0.112 |
| >50 years | 222 (71.4) | 55 (83.3) | 22 (78.6) | |
| ER Hormone receptor status | ||||
| ER negative | 115 (37) | 22 (33.3) | 16 (57.1) | 0.078 |
| ER positive | 196 (63) | 44 (66.7) | 12 (42.9) | |
| PR Hormone receptor status | ||||
| PR negative | 131 (42.1) | 23 (34.8) | 15 (53.6) | 0.232 |
| PR positive | 180 (57.9) | 43 (65.2) | 13 (46.4) | |
| Combination of hormone receptor and HER-2/neu status | ||||
| triple negative | 75 (24.1) | 8 (12.3) | 7 (25) | 0.108 |
| no triple negative | 236 (75.9) | 57 (87.7) | 21 (75) | |
| Histological type | ||||
| no special type | 261 (83.9) | 61 (92.4) | 25 (89.3) | 0.172 |
| invasive lobular | 25 (8) | 2 (3) | ||
| other types | 25 (8) | 3 (4.5) | 3 (10.7) | |
| pT-stage | ||||
| pT1 | 130 (41.8) | 31 (47) | 13 (46.4) | 0.690 |
| pT2/pT3/pT4 | 181 (58.2) | 35 (53) | 15 (53.6) | |
| nodal status | ||||
| pN0 | 161 (56.1) | 28 (45.2) | 12 (46.2) | 0.215 |
| pN1 - pN3 | 126 (40.5) | 34 (51.5) | 14 (50) |